Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023) - Scorecard - MDSpire
Advertisement
Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023)
Clinical Scorecard: Trends and Sociodemographic Differences in Cancer Prevalence Among U.S. Adults: Insights from National Health Interview Survey Data (2019–2023)
At a Glance
Category
Detail
Condition
Cancer prevalence
Key Mechanisms
Self-reported physician diagnoses, stratified by demographics and social factors
Target Population
U.S. adults aged 18 years and older
Care Setting
National Health Interview Survey
Key Highlights
Overall cancer prevalence stable at 9.8% from 2019 to 2023
Significant disparities in cancer prevalence by race and socioeconomic factors
Breast cancer prevalence in females increased slightly; cervical cancer declined
Prostate cancer prevalence rose slightly among males, highest in Black males
Skin cancer prevalence increased in females, particularly among White adults
Guideline-Based Recommendations
Diagnosis
Cancer prevalence assessed through self-reported physician diagnoses
Management
Targeted cancer control strategies needed to address disparities
Monitoring & Follow-up
Ongoing assessment of cancer prevalence trends across demographics
Risks
Higher prevalence observed among older adults and those with low social vulnerability
Patient & Prescribing Data
U.S. adults with self-reported cancer diagnoses
Incremental healthcare expenditures associated with cancer prevalence
Clinical Best Practices
Utilize stratified data to inform cancer prevention strategies
Address racial and socioeconomic disparities in cancer care
